Codex Genetics

runs a clinical metagenomic whole-genome-sequencing platform with dedicated gastroenterological, gastric and metabolic diagnostic panels for clinical use.

Country
United States
Commercial Metagenomic WGS / CoGenesis panels
Coverage
CNEUINUS
diagnostics-medtech
Regulatorsfdaemanmpa

Verifiable facts

FactValueSource
Funding$41,300 total fundingprospeo.io
Headcount11-20 employeesprospeo.io · codexgenetics.com
Revenue$1,283,325 annual revenueprospeo.io
Production siteHong Kong Science Park, Hong Kongcodexgenetics.com · ncbi.nlm.nih.gov
CertificationISO 15189, ISO 27001, GenQA/UK NEQAS accreditedcodexgenetics.com

Independent sources: ncbi.nlm.nih.gov · prospeo.io

Technologies
NameClusterRisk
Microbiome diagnostic panelsdiagnostics-medtechMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.